Recession Boosts STEM Enrollment

Undergraduate students are more likely to enroll in engineering and biology since the last economic downturn, a survey finds.

Written byRina Shaikh-Lesko
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, ARIANA ROSE TAYLOR-STANLEYSince the beginning of the recession, college freshmen have been more likely to enroll in science, technology, engineering, and mathematics (STEM) fields, and engineering and biology in particular, according to survey results presented at the American Educational Research Association annual meeting held in Philadelphia last week (April 5). Jerry Jacobs of the University of Pennsylvania and Linda Sax of the University of California,Los Angeles (UCLA), studied intended majors of new undergraduate students at four-year universities based on the Freshman Survey of the Cooperative Institutional Research Program as well as a larger survey of freshmen conducted by UCLA.

From 1997 to 2005, the rate of freshmen planning on enrolling in STEM fields fell to a low of 20.7 percent, the researchers found. Between 2007 and 2011, however, freshmen with anticipated STEM majors rose from 21.1 percent to 28.2 percent, Inside Higher Ed reported. Engineering saw the largest increase, with 57.1 a percent bump during that same time. Biology had the second-highest increase—enrollment shot up 28.2 percent in those five years. Other STEM fields also saw increases, although at more moderate paces. Mathematics saw a 12.6 percent increase; physical sciences, 11.1 percent. Computer science enrollment remained at the same levels as previous years, the researchers found.

The increase did not come at the expense of humanities and arts majors, as many have feared. Humanities ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies